TEVA
Teva Pharmaceutical Industries Limited
stockNYSE
At CloseOct 21, 2026 3:59:58 PM EDT
40.61USD-0.588%(-0.24)4,593,885
Pre-marketOct 21, 2026 9:29:30 AM EDT
40.19USD-1.616%(-0.66)
After-hoursOct 21, 2026 4:32:30 PM EDT
40.58USD-0.074%(-0.03)
Loading…
Loading…
47.29B
Healthcare
Drug Manufacturers-Specialty & Generic
HQ
Tel Aviv, Petah Tikva, Israel
51,800
Previous Close
$40.85
Beta
0.75
52-Week High
$42.02 2026-10-09
52-Week Low
$18.83 2025-10-22
SMA 50
$38.48
SMA 200
$34.25
Avg. Vol 10D
7.22M
Avg. Vol 30D
5.87M
Avg. Vol 90D
5.63M
Relative Vol
0.68
1.17B
1.11B
95.02%
29,848,805
2.56%
5.40
49%/51%
39.12%
19.94%
0.2500%
9,900,000
50
49,339
443,776
Nov 3, 2026 (13d)
Nov 27, 2017 · $0.072
Jul 1, 2004 · 2-for-1
17.3B
706.0M
Oct 20, 2026
Oct 12, 2026
Teva to Host R&D Day on Wednesday, November 11 in New York City · 
Financial Post
Oct 10, 2026
Hospital group files lawsuit to stop 340B rebate pilot again · 
Seeking Alpha
Oct 9, 2026
TEVA Profile
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals.
TEVA Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 40.72 | 2026-10-14 | -0.42% | -0.839 |
| 1M | 40.06 | 2026-09-21 | +1.22% | 0.349 |
| 3M | 31.35 | 2026-07-21 | +29.35% | -0.236 |
| 6M | 31.29 | 2026-04-21 | +29.59% | 0.046 |
| 1Y | 18.99 | 2025-10-21 | +113.53% | 0.753 |
| 2Y | 18.18 | 2024-10-21 | +123.05% | — |
| 5Y | 10.14 | 2021-10-21 | +299.90% | 0.894 |
TEVA Stock Summary
Teva Pharmaceutical Industries Limited (NYSE:TEVA) stock price today is $40.55, and today's volume is 3,964,312. TEVA is down 0.734% today. The 30 day average volume is 5.87M. TEVA market cap is $47.29B with 1.17B shares outstanding.